Zobrazeno 1 - 10
of 13
pro vyhledávání: '"V B, Morhenn"'
Autor:
J. M. Schroder, P von den Driesch, Michael P. Schön, E. M. Farber, V. B. Morhenn, M. F. Holick, Siba P. Raychaudhuri, Wolf-Henning Boehncke, E. W. Rosenberg, Brian J. Nickoloff
Publikováno v:
Experimental Dermatology. 9:359-375
The etiology and pathogenesis of psoriasis--one of the most common chronic, inflammatory, hyperproliferative skin disorders of man--have long fascinated dermatologists, pathologists and biologists alike. Here, we have a model disease that offers to s
Autor:
B J, Nickoloff, J M, Schröder, P, von den Driesch, S P, Raychaudhuri, E M, Farber, W H, Boehncke, V B, Morhenn, E W, Rosenberg, M P, Schön, M F, Holick
Publikováno v:
Experimental Dermatology, Vol. 9, No 5 (2000) pp. 359-375
The etiology and pathogenesis of psoriasis--one of the most common chronic, inflammatory, hyperproliferative skin disorders of man--have long fascinated dermatologists, pathologists and biologists alike. Here, we have a model disease that offers to s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::336f499abf2139422cdc544c6a88185c
https://archive-ouverte.unige.ch/unige:29814
https://archive-ouverte.unige.ch/unige:29814
Publikováno v:
Second messengers and phosphoproteins. 14(1-2)
We have examined the ability of recombinant human epidermal growth factor (EGF) and bradykinin (BK) to stimulate formation of inositol polyphosphates and sn-1,2-diacylglycerol (DAG), and mobilize intracellular Ca2+ ([Ca2+]i) in adult human keratinocy
Autor:
V. B. Morhenn
Publikováno v:
Archives of Dermatology. 123:1633-1637
Publikováno v:
The Journal of biological chemistry. 254(2)
As a model cell culture system for studying polyoma-mediated control of host gene expression, we isolated methotrexate-resistant 3T6 cells in which one of the virus-induced enzymes, dihydrofolate reductase, is a major cellular protein. In highly meth
Autor:
V B, Morhenn, K, Pregerson-Rodan, R H, Mullen, G S, Wood, B J, Nickoloff, S A, Sherwin, E M, Farber
Publikováno v:
Archives of dermatology. 123(12)
Twenty-three patients with chronic plaque-type psoriasis were treated with intramuscular administration of human recombinant interferon gamma. Patients were treated with doses of 0.01 to 0.25 mg/m2 daily (five out of seven days) for four weeks, or 0.
Autor:
V B, Morhenn, E A, Pfendt
Publikováno v:
Methods in enzymology. 108
Publikováno v:
The Journal of clinical investigation. 76(5)
A murine monoclonal antibody was generated against human skin cells obtained from psoriatic plaques. The antibody, called VM-2, recognizes an epitope expressed on the basal cell layer of human skin and other epithelia. VM-2 also binds to cultured cel
Autor:
V B, Morhenn, H I, Maibach
Publikováno v:
Acta dermato-venereologica. 54(2)
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology. 51(6)
To extend our initial observation that recombinant gamma-interferon induced expression of class II major histocompatibility (HLA-DR) antigen on normal cultured human keratinocytes, we studied the antiproliferative effects of recombinant alpha- and ga